Recent advances in the study of Pin1 and its inhibitors

Yaoxue Xuebao

Volumn 43, Issue 1, 2008, Pages 9-17

  Zhang, Chong Jing ^a   Zhang, Zhi Hui ^b   Xu, Bai Ling ^a   Wang, Yu Ling ^b  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Neoplasms; Peptidyl prolyl isomerase; Pin1 inhibitor; Review

Indexed keywords

ENZYME INHIBITOR; NIMA INTERACTING PEPTIDYLPROLYL ISOMERASE; NIMA-INTERACTING PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE; PHOSPHOPROTEIN;

APOPTOSIS; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; MITOSIS; NEOPLASM; PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SYNTHESIS;

APOPTOSIS; ENZYME INHIBITORS; HUMANS; MITOSIS; NEOPLASMS; PEPTIDYLPROLYL ISOMERASE; PHOSPHOPROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 38849109521     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Blume-Jensen P, Hunier T. Oncogenic kinase signaling [J]. Nature, 2001, 411:355-365.
2. Lu KP, Liou YC, Zhou XZ. Pinning down the prolinedirected phosphorylation signaling [J]. Trends Cell Biol, 2002, 12:164-172.
3. Lu KP, Hanes SD, Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis [J]. Nature, 1996, 380:544-547.
4. Ranganathan R, Lu KP, Hunter T, et al. Structural and functional analysis of the mitotic rotamase pin1 suggests substrate recognition is phosphorylation dependent [J]. Cell, 1997, 89:875-886.
5. Zhang Y, Daum S, Wildemann D. Structural basis for high-affinity peptide inhihiton of human Pin1 [J]. ACS Chem Biol, 2007, 2:320-328.
6. Zhou XZ, Kops O, Werner A, et al. Pin-dependent prolyl isomerization regulates dephosphorylation of cdc25c and tau proteins [J]. Mol Cell, 2000, 6:873-883.
7. Shen M, Stukenberg PT, Kirschner MW, et al. The essential mitotic peptidyl-prolyl isomerase Pin hinds and regulates mitosis-specific phosphoproteins [J]. Genes Dev, 1998, 12:706-720.
8. Bao L, Kimzey A, Sauter G, et al. Prevalent overexpression of prolyl isomerase Pin1 in human cancers [J]. Am J Pathol, 2004, 164:1727-1737.
9. Lu KP. Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics [J]. Cancer Cell, 2003, 4:175-180.
10. Wulf G, Ryo A, Liou YC, et al. The prolyl isomerase Pin1 in breast development and cancer [J]. Breast Cancer Res, 2003, 5:76-82.
11. Kuramochi J, Arai T, Ikeda S. et al. High Pin1 expression is associated with tumor progression in colorectal cancer [J]. J Surg Oncol, 2006, 94:155-160.
12. Rippmann JF, Hobbie S, Daiber C, et al. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis [J]. Cell Growth Differ, 2000, 11:409-416.
13. Pang RW, Lee TK, Man K. et al. Pin1 expression contributes to hepatic carcinogenesis [J]. J Pathol, 2006, 210:19-25.
14. Ryo A, Uemura H, Ishiguro H, et al. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer [J]. Clin Cancer Res, 2005, 11:7523-7531.
15. Liou YC, Ryo R, Huang HK, et al. Loss of Pin1 function in the mouse resembles the cyclin D1-null phenotypes [J]. Proc Natl Acad Sci USA, 2002, 99: 1335-1340.
16. Fujimori F, Takahashi K, Uchida C, et al. Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest [J]. Biochem Biophys Res Commun, 1999, 265;658-663.
17. Zhang YX, Füssel S, Reimer L, et al. Substrate-based design of reversible Pin1 inhibitors [J]. Biochemistry, 2002, 41:11868-11877.
18. Bayer E, Thutewohl M, Christner C. Identification of hPin1 inhibitors that induce apoptosis in a mammalian Ras transformed cell line [J]. Chem Commun, 2005, 4: 516-518.
19. Wildemann D, Erdmann F, Alvarez BH, et al. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries [J]. J Med Chem, 2006, 49:2147-2150.
20. Wang XJ, Xu BL, Mullins AB, et al. Conformationally locked isostere of phosphoser-cis-pro inhibits Pin1 23-fold better than phosphoser- trans-pro isostere [J]. J Am Chem Soc, 2004, 126:15533-15542.
21. Yaffe MB, Schutkowski M, Shen M, et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism [J]. Science, 1997, 278:1957-1960.
22. Felicia E, Blacksburg VA. Transition-state inhibitors of Pin1, alpha-ketoamide-containing peptidomimetics, and synthesis thereof: US, 20070027076 [P]. 2007-02-01.
23. Henning L, Christner C, Kipping M. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone [J]. Biochemistry, 1998, 37:5953 -5960.
24. Chao SH, Greenleaf AL, Price DH. Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription [J]. Nucl Acids Res, 2001, 29:767-773.
25. Webb JL. Enzyme and Metabolic Inhibitors [M]. New York: Academic Press, 1963:1996.
26. Uchida T, Takamiya M, Takahashi M, et al. Pin1 and par14 peptidyl prolyl isomerase inhibiters block cell proliferation [J]. Chem Biol, 2003, 10:15-24.
27. Daum S, Erdmann F, Fischer G. Aryl indanyl ketones: efficient inhibitors of the human peptidyl prolyl cis/trans isomerase [J]. Angew Chem Int Ed, 2006, 45:7454-7458.
28. Tibbitts T, Mckee TD, Suto RK, et al. Pin1-modulating compounds and methods of use thereof: WO, 2004028535 [P]. 2004-04-08.
29. Suto RK, Mckee TD. Pin1-modulating compounds and methods of use thereof: WO, 2003073999 [P]. 2003-09-12.
30. Stragies R, Tradler T, Hummel G, et al. New compounds for the inhibition of rotamases use thereof: WO, 2004026815 [P]. 2004-04-01.
31. Suto RK, Sowadski J, Mckee, TD. Pin1-modulating compounds and methods of use thereof: WO, 2003074497 [P]. 2003-09-12.
32. Suto RK, Mckee TD. Pin1-modulating compounds and methods of use thereof: WO, 2003074550 [P]. 2003-09-12.
33. 2) Thr-Pro-specific peptidyl-prolyl-cis/trans-isomerases: WO, 2003093258 [P]. 2003-11-13.
34. Dagostino EF, Margosiak SA, Dong L, et al. Phosphate/sulfate ester compounds and pharmaceutical compositions for inhibiting protein ineracting NIMA (PIN1): WO, 2004087720 [P]. 2004-10-14.
35. Lu PJ, Zhou XZ, Shen M, et al. A function of WW domains as phosphoserine- or phosphothreonine-binding modules [J]. Science, 1999, 283:1325-1328.
36. Verdecia MA, Bowman ME, Lu KP, et al. Strural basis for phosphoserine-proline recognition by group IV WW domains [J]. Nat Struct Biol, 2000, 7:639-643.
37. Ryo A, Nakamura N, Wulf G, et al. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC [J]. Nat Cell Biol, 2001, 3:793-801.
38. Ryo A, Liou YC, Wulf G, et al. Pin1 is an E2F target gene essential for the Neu/Ras-induced transformation of mammary epithelial cells [J]. Mol Cell Biol, 2002, 22: 5281-5295.
39. Ryo A, Liou YC, Lu KP, et al. Prolyl isomerase Pin1, a catalyst for oncogenesis and a potential anticancer target [J]. J Cell Sci, 2003, 116:773-783.
40. Wulf GM, Liou YC, Ryo A, et al. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage [J]. J Biol Chem, 2002, 277:47976-47979.